Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
A review of the epidemiology and approaches to the treatment of social anxiety disorder
Autore:
Sareen, J; Stein, M;
Indirizzi:
Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA Univ Calif SanDiego La Jolla CA USA 92093 ychiat, La Jolla, CA 92093 USA
Titolo Testata:
DRUGS
fascicolo: 3, volume: 59, anno: 2000,
pagine: 497 - 509
SICI:
0012-6667(200003)59:3<497:AROTEA>2.0.ZU;2-K
Fonte:
ISI
Lingua:
ENG
Soggetto:
NATIONAL-COMORBIDITY-SURVEY; DOUBLE-BLIND; CONTROLLED TRIAL; PHOBIA; PLACEBO; MOCLOBEMIDE; PREVALENCE; PHENELZINE; PAROXETINE; SAMPLE;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
66
Recensione:
Indirizzi per estratti:
Indirizzo: Stein, M Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr 0985, La Jolla, CA 92093 USA Univ Calif San Diego 9500 Gilman Dr 0985 La Jolla CA USA 92093 SA
Citazione:
J. Sareen e M. Stein, "A review of the epidemiology and approaches to the treatment of social anxiety disorder", DRUGS, 59(3), 2000, pp. 497-509

Abstract

This review presents current literature on the epidemiology and treatment of social anxiety disorder (social phobia). This illness has been demonstrated to be the most common anxiety disorder with a 1-year prevalence of 7 to8% and a lifetime prevalence of 13 to 14% in patients aged between 15 and 54 years. Social anxiety disorder can be classified into 2 subtypes, discrete and generalised. Morbidity is high with this disorder, and 70 to 80% of patients have co-morbid mental disorders. Although effective treatments areavailable, social anxiety disorder is under-recognised and under-treated. Treatments that have been systemically studied and have shown efficacy in patients with social anxiety disorder include pharmacotherapy (selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, reversible inhibitors of monoamine-A and benzodiazepines) and short term psychotherapies (cognitive behaviour therapy, social skills training and exposure in vivo therapy). beta-blockers are useful in treating performance-related anxiety. Fewpublished data are available on the treatment of social anxiety disorder with a combination of pharmacotherapy and psychotherapy. We conclude this review by discussing proposed algorithms for treating both subtypes of socialanxiety disorder.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/12/20 alle ore 20:18:41